GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hims & Hers Health Inc (NYSE:HIMS) » Definitions » Operating Income

Hims & Hers Health (Hims & Hers Health) Operating Income : $-8.3 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hims & Hers Health Operating Income?

Hims & Hers Health's Operating Income for the three months ended in Mar. 2024 was $9.9 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was $-8.3 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Hims & Hers Health's Operating Income for the three months ended in Mar. 2024 was $9.9 Mil. Hims & Hers Health's Revenue for the three months ended in Mar. 2024 was $278.2 Mil. Therefore, Hims & Hers Health's Operating Margin % for the quarter that ended in Mar. 2024 was 3.56%.

Hims & Hers Health's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Hims & Hers Health's annualized ROC % for the quarter that ended in Mar. 2024 was 18.38%. Hims & Hers Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 77.39%.


Hims & Hers Health Operating Income Historical Data

The historical data trend for Hims & Hers Health's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hims & Hers Health Operating Income Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
-74.41 -15.14 -115.04 -68.70 -29.45

Hims & Hers Health Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.26 -9.24 -8.55 -0.40 9.90

Hims & Hers Health Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hims & Hers Health  (NYSE:HIMS) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Hims & Hers Health's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=39.612 * ( 1 - 10.28% )/( (185.147 + 201.651)/ 2 )
=35.5398864/193.399
=18.38 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=441.186 - 79.454 - ( 220.981 - max(0, 88.468 - 265.053+220.981))
=185.147

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=448.106 - 78.045 - ( 203.592 - max(0, 93.324 - 261.734+203.592))
=201.651

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Hims & Hers Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=39.612/( ( (45.731 + max(-43.115, 0)) + (56.634 + max(-33.638, 0)) )/ 2 )
=39.612/( ( 45.731 + 56.634 )/ 2 )
=39.612/51.1825
=77.39 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(5.705 + 22.464 + 15.903) - (79.454 + 7.733 + 0)
=-43.115

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.405 + 29.826 + 21.911) - (78.045 + 13.735 + 0)
=-33.638

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Hims & Hers Health's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=9.903/278.171
=3.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Hims & Hers Health Operating Income Related Terms

Thank you for viewing the detailed overview of Hims & Hers Health's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Hims & Hers Health (Hims & Hers Health) Business Description

Traded in Other Exchanges
Address
2269 Chestnut Street, Suite 523, San Francisco, CA, USA, 94123
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
Executives
Andrew Dudum director, 10 percent owner, officer: Chief Executive Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Oluyemi Okupe officer: Chief Financial Officer 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Soleil Boughton officer: See Remarks 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Lynne Chou O'keefe director 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Irene Becklund officer: Interim PFO/PAO 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Melissa Baird officer: Chief Operating Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
David B Wells director C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130
Alex Bard director 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Ivp Executive Fund Xvi, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025
Jules A. Maltz director 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Christiane Pendarvis director 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Michael Chi officer: Chief Marketing Officer 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Somesh Dash 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Jack Abraham 10 percent owner 1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129
Patrick Harrison Carroll officer: Chief Medicall Officer 2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123